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Abstract. This study examined the effectiveness of leuprolide, agonadotrophin-releasinghormoneagonist, in suppressing
rut-associated events in farmed male red deer. In mid-January (~6 weeks before the rut period in the southern hemisphere)
adult red deer (Cervus elaphus scoticus) stags that had been allocated to three groups (n = 10 per group) received leuprolide,
administered subcutaneously in a 90-day release formulation, at zero (control), low (22.5 mg) or high (45 mg) doses.
Following treatment with leuprolide there was evidence of suppression of mean plasma luteinising hormone concentration
that was significant (P < 0.05) at 9 weeks. Mean plasma testosterone concentration of all three groups rose following
treatment, then declined prematurely in the low- and high-dose leuprolide-treated groups, so that it was significantly
(P < 0.05) suppressed (0.66 0.29 and 2.0 0.88 ng mL–1, low and high dose respectively) in early April when the peak
value (9.0  1.94 ng mL–1) was recorded from control stags. A reduction in mean liveweight occurred in all three groups
through February–April and this did not differ among treatments. However, a corresponding reduction in mean body
condition score was greater in the control stags (P < 0.05). There was little effect of leuprolide treatment on aggressive
behaviours, but it lowered roaring frequency in the latter period of the rut. The results indicate that this gonadotrophin-
releasing hormone agonist has potential for application in the deer farming industry to suppress undesirable effects of the rut.
Additional keywords: agonistic behaviour, contraception, luteinising hormone, liveweight, testosterone, rut.
Introduction
In the deer farming sector there are concerns about aggressive
behaviour and losses of liveweight of stags during the rut period,
and, in regions of the world where deer are becoming
overabundant, there is a call for humane methods of fertility
control to manage populations of wild deer. In both of these
situations it is likely that use of chemical agents that suppress
reproductive function in deer stags will become an important
management tool. Twomajor approaches to achieve such control
of reproductive function in male mammals are use of vaccines
raised against gonadotrophin-releasing hormone (GnRH) to
achieve immunocastration, and use of GnRH agonists to
modify function of the pituitary gland and, thus, disrupt the
reproductive control axis (Padula 2005; Trigg et al. 2006).
Immunisation of red deer (Cervus elaphus scoticus) stags
against GnRH has been used with variable success in adult
(Lincoln et al. 1982; Barrell et al. 2002) and immature
(Freudenberger et al. 1993) red deer males, as well as in
white-tailed bucks (Odocoileus virginianus, Miller et al.
2000). In the case of GnRH agonists, Lincoln (1987) showed
stimulationof reproductive function in reddeer stags following an
infusion of buserelin. This result indicated a stimulatory action of
buserelin, but the effects of other GnRH agonists could be
inhibitory, and, thus, the potential of any single compound to
inhibit reproduction shouldbe investigatedonan individual basis.
An alternative approach is the use of contraceptive steroids.
Studies with deer have demonstrated some success in
suppression of male reproductive activity with synthetic
progestagens such as melengestrol acetate (fallow deer
Dama dama, Wilson et al. 2002) and medroxy progesterone
acetate (red deer, Muir et al. 1982).
However, as well as being dependent on their mode of action
on the reproductive axis, much of the potential for use of
chemical agents rests on their mechanism of delivery. Recent
advances in development of biodegradable implants containing
GnRH agonists have led to sustained-release delivery systems
that have provided long-term contraceptive effects in heifers and
cows following use of implants containing deslorelin
(D’Occhio et al. 2002). In deer, biodegradable implants
containing leuprolide, another GnRH agonist, have
successfully generated reversible long-term contraception in
wapiti (Cervus elaphus) females (Baker et al. 2002, 2005;
Conner et al. 2007). The present study was conducted to
determine whether such implants containing leuprolide
would mitigate negative effects of the rut on liveweight and
body condition in red deer males – another subspecies of Cervus
elaphus.
Materials and methods
Animals
Thirty adult (5 years old) red deer (Cervus elaphus scoticus)
stags were managed as three separate experimental groups on
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three adjacent paddocks grazing pasture comprising mainly
perennial ryegrass and white clover with water available
ad libitum at the Research Farm, Lincoln University, in
Canterbury, New Zealand (4338060S, 17228060E). The
groups were interchanged among the three paddocks
each week. All procedures used in the study were conducted
with approval from the Lincoln University Animal Ethics
Committee.
Experimental procedure
Stags were allocated to one of three treatment groups (n = 10
per group) as follows: controls (zero dose leuprolide, i.e. glycine
in Atrigel), low-dose leuprolide (22.5 mg leuprolide acetate in
Atrigel) or high-dose leuprolide (45 mg leuprolide acetate
in Atrigel, previously shown to be highly effective in wapiti
females, Baker et al. 2002). Leuprolide was provided as
lyophilised leuprolide acetate (D-Leu6-GnRH-Pro9-ethylamide
acetate) powder in 22.5-mg aliquots. The 90-day slow-release
formulation was prepared by mixing each leuprolide powder
aliquot with 1 mL of Atrigel (Atrix Laboratories, Fort Collins,
CO, USA) in a syringe immediately before s.c. injection into the
neck of each stag at the start of the trial, in January (mid-summer).
For handling procedures, stags were mustered every 3 weeks
from their paddocks into abarnwhere theywereplaced singly into
a padded side-loading crush. Liveweight, scrotal diameter
(anterior-posterior distance at equator of scrotal mass
measured by vernier caliper) and body condition score (scored
1 to 5, where 1 is very lean, 5 is fat, Audigé et al. 1998) were
recorded and a single blood sample (10 mL) was obtained via
jugular venipuncture into a heparinised evacuated glass
container. Blood samples were centrifuged for 10 min (1000g)
within 1 h of collection and the resultant plasmawas stored frozen
(20C). Antler growth was monitored by visual appraisal.
Behavioural observations
Behavioural observations were conducted from 0830 to 0930
hours and from 1545 to 1645 hours each day for 28 days (late
April to late May) during the rut period. The animals were
observed from a tower that concealed the observer but enabled
monitoring of all three groups during the same period. A focal
sampling technique was used to record the occurrence of the
following behaviours: chasing, roaring, fighting, displaying,
pacing, rubbing, wallowing and riding. This involved
observation of a focal group of animals and recording
behaviours of all individuals in the focal group. Frequency
was determined as the total of the number of observations
recorded every 5 min for the 120-min observation period
each day. In addition to the focal sampling, the number of
animals that were active, standing, resting and grazing was
recorded every five minutes. The data from every 7 days were
pooled to produce weekly means.
Hormone radioimmunoassay
Plasma luteinising hormone (LH) concentration wasmeasured in
duplicate 100-mLaliquots, usingaheterologous, double-antibody
radioimmunoassay. The iodinated tracer and the reference
preparation were prepared by using purified ovine LH
(NIDDK-oLH-I-2, no. AFP7071B). Standards were prepared
by dissolving the reference LH in low-LH cervine plasma
obtained from hinds treated with medroxyprogesterone
acetate (Promone E, Upjohn Inter-American Corp., Auckland,
NZ). The primary antiserum (NIDDK anti-o-LH1, AFP-
192 279), raised in a rabbit against highly purified ovine LH,
was used at a dilution of 1 : 250 000. Specificity of the primary
antiserum, expressed in terms of cross-reactivity with pituitary
hormones other than LH, has been established (by NIDDK and
in sheep) to be 5.4% for ovine FSH, 0.6% for ovine growth
hormone, 0.1% for ovine thyroid stimulating hormone, and
<0.01% for ovine prolactin, arginine, vasopressin and
adrenocorticotrophic hormone. A suspension of cellulose
coated with anti rabbit gamma globulin antibody (Sac-cel,
AA-SAC1, IDS, Boldon, UK) was used to precipitate bound
tracer. Samples with count differences greater than 10% were
repeated. The LH measurements were carried out over three
assays. Intra-assay Cvv. at 5.3 ng mL–1 were 10.9, 11.1, and
10.7%, respectively, and inter-assay CV. was 11.8% for plasma
pools displacing radio-labelled LH to, respectively, 35.1, 33.7
and 32.1% of the total bound. Because ovine LH was used for
the standard source in this assay, results are strictly ovine LH
equivalents. For simplicity they are expressed here as ng LH.
Plasma testosterone concentration was measured by direct
radioimmunoassay (Garnier et al. 1978) using a non-extracted
technique described by Schanbacher and D’Occhio (1982). This
assay used [1, 2, 6, 7, H3] testosterone (TRK 402, Amersham,
Little Chalfont, Buckinghamshire, UK) as tracer and rabbit-anti-
testosterone-11-bovine serum albumin serum (#250, supplied
by GD Niswender, Colorado State University, Fort Collins,
CO, USA) as antiserum. Sensitivity of the assay was 0.15 ng mL–1.
Intra-assay coefficients of variation (CV) were 16, 9.6,
and 8.5%. The percentages bound were, respectively, 54, 29
and 68%. Inter-assay CV was 16.6%. Serially diluted deer
plasma exhibited parallel binding to that of the standard
curve (Shi and Barrell 1992).
Statistical analyses
Data for plasma LH and testosterone and concentrations,
liveweight, scrotal diameter and the behavioural records were
analysed by using SPSS (Statistical Package for Social Sciences,
version 12.0, SPSS, Chicago, IL, USA). Hormonal data were
transformed to their logarithm (base 10) before analysis.
For transformed plasma LH and testosterone concentrations
and for scrotal diameter and liveweight, a 1-way ANOVAwith a
post hoc Scheffé analysis was used to compare differences
between groups. Body condition score and behavioural
observations were analysed using two non-parametrical tests
(Kruskall–Wallis and Mann–Whitney U). The influence of
treatment on body condition score and agonistic behaviour
during the trial was examined by a post hoc Scheffé analysis.
Results are presented as the mean  s.e.
Results
Liveweight and body condition score
Mean liveweight of each group of stags (Fig. 1) tended to
peak in late summer (February), decline during autumn
(March, April) and remain low during winter (May, June).
There was no detectable effect of leuprolide treatment on
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mean liveweight during the trial. Mean body condition scores
were lower in April than in December (P < 0.01), but increased
slightly (P < 0.01) between April and June (Fig. 2). Throughout
the study, leuprolide-treated stags had higher (P < 0.05) mean
body conditions scores than control animals.
Scrotal diameter
Overall mean (n = 30) scrotal diameter tended to increase
during summer (from 4.6  0.21 to 5.4  0.22 cm) and
decline in autumn, reaching 4.5  0.19 cm in May. There was
a trend (0.05 < P < 0.1) for leuprolide-treated groups to have
slightly lower mean scrotal diameters than controls during
autumn.
Antler growth
Some stags in the leuprolide-treated groups (three per group)
had minor (a few cm) antler growth, whereas there was no antler
growth in any control group stag during the study period.
LH and testosterone
Mean plasma concentrations of LH and testosterone tended to
increase in late summer (February, March) peak thereafter
(March, April), and decline during autumn (April) (Fig. 3).
At 9 weeks post treatment, in April, leuprolide-treated
groups had lower (P < 0.01) mean plasma LH and testosterone
concentrations than controls (Fig. 3). In May, mean plasma
testosterone concentration was low in all cases although it was
higher (P < 0.05) in the low leuprolide dose group than in the
other two groups.
Behaviour
The overall incidence of chasing and fighting behaviours
declined (P < 0.05) with time during the period of
observations. Roaring activity (Fig. 4) in control and low-dose
groups increased (P < 0.05) to the highest level in early May,
and there was evidence (P < 0.05) of earlier cessation of
roaring in the low-dose group. In the high-dose group the
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Fig.1. Mean liveweight of reddeer stags (n=10per group) treated (at arrow)
with low dose (22.5 mg,~), high dose (45 mg,&) leuprolide implants or
vehicle-only implants (controls, *) in January (mid-summer). Data were
recorded approximately monthly from December until June. The horizontal
bar indicates approximate duration of the rut. Vertical bars denote s.e.
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Fig. 2. Mean body condition score of red deer stags (n = 10 per group)
treated with low dose (22.5 mg, ~), high dose (45 mg, &) leuprolide
implants or vehicle-only implants (controls, *) in January (mid-summer).
Datawere recorded on three occasions betweenDecember and June and range
from 1 (poor condition) to 5 (fat condition). Vertical bars denote
s.e. *Significant difference (P < 0.05) between groups.
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Fig. 3. Mean (a) plasma luteinising hormone (LH), and (b) testosterone
concentration of red deer stags (n = 10 per group) treated (at arrow) with low
dose (22.5mg,~), high dose (45mg,&) leuprolide implants or vehicle-only
implants (controls, *) in January (mid-summer). Data were recorded
approximately monthly from December until May. The horizontal bar
indicates approximate duration of the rut. Statistics performed after
transformation of the data to their log10. Vertical bars denote s.e.
*Significant difference (P < 0.05) between groups.
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incidence of roaring was low (P < 0.05) throughout the
observation period (Fig. 4).
Discussion
The sustained release preparation of leuprolide used here on
male deer produced a premature suppression of the rut-
associated events. This finding is based on the effects recorded
on plasma concentrations of LH and testosterone and on changes
in scrotal diameter and reproduction-related behaviours –
aggression and roaring. Rut-associated losses in liveweight
were not affected by leuprolide but there was some
evidence for a treatment-induced amelioration of loss of body
condition. The findings show that slow release delivery of the
GnRHagonist, leuprolide, haspotential as ameans for controlling
some rut-associated events in farmed male red deer. It is
noteworthy that the suppressive effects recorded here were not
dramatic, there were only minor effects on reproductive-related
behaviours, and leuprolide treatment did not prevent loss of
liveweight by stags in autumn. However, it is feasible that
higher-dose preparations may be more effective and merit
further study. The occurrence of some antler growth, as
recorded here, accords with suppression of testosterone
secretion (Muir et al. 1988) induced by treatment with
leuprolide, but such growth may be regarded by farmers as a
nuisance.
In general, these results from use of a sustained-release
preparation of leuprolide in male red deer parallel those
obtained with their closely related female counterparts, elk –
also known as wapiti. In this subspecies (Baker et al. 2002, 2005;
Conner et al. 2007) leuprolide-treated animals did not become
pregnant during the breeding season following treatment. In
accord with the present results for males, Baker et al.
(2002, 2005) also reported suppression of plasma LH
concentration in the females. Also, in concert with results of
the studies in females, our observations showed little effect of
leuprolide on behaviour of the males. However, we did not
attempt to measure libido specifically or to examine whether
the stags were willing to mount females.
In the farmed deer sector, rut-associated loss of liveweight
and body condition in stags can be regarded as detrimental to
productivity and to potential well being of stags. Hence,
the indication that leuprolide use was associated with a
reduction in severity of the loss of body condition in the low-
and high-dose leuprolide-treated stags provides a positive note
for application of this technology on commercial farms. This
finding contrasts with the winter-time loss of body fat
composition of leuprolide-treated hinds, compared with
pregnant controls (Conner et al. 2007). However, those
authors were unable to explain this unexpected result, and it is
likely that the possible benefit of agonist treatment on body
condition of stags, as indicated in the present results, will
endure in further studies.
Another concern for farmers is aggressiveness in the
behaviour of rutting stags. However, the behavioural
observations recorded here show little evidence that this aspect
was affected by leuprolide, although there was some treatment-
related suppression of roaring activity. During the observation
periods, the stags spent ahighproportionof the timegrazing (up to
70% of the time) or resting (up to 60% of the time) and there
was comparatively little aggressive behaviour. It is, thus, not
possible to reach any firm conclusion about this aspect of stag
behaviour in relation to the treatment.
In spite of some practical limitations, as pointed out by
Conner et al. (2007), the present findings show that sustained
delivery preparations containing GnRH agonists have promise
as acceptable agents for the reproductive manipulation of
farmed deer.
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